Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Cited by (1,000)

Items 101–200 of 1,000

  1. Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy
    Alexandra C. Walls, M. Alejandra Tortorici, Brandon Frenz, Joost Snijder, Wentao Li, Felix Augusto Rey, Frank DiMaio, Berend‐Jan Bosch, David Veesler · 2016 · Nature Structural & Molecular Biology
  2. Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS
    Jan Felix Drexler, Victor M. Corman, Christian Drosten · 2013 · Antiviral Research
  3. Global Epidemiology of Bat Coronaviruses
    Antonio C. P. Wong, Xin Li, Susanna K. P. Lau, Patrick C. Y. Woo · 2019 · Viruses
  4. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
    Eun Kim, Géza Erdös, Shaohua Huang, Thomas W. Kenniston, Stephen C. Balmert, Cara Donahue Carey, Victor Stalin Raj, Michael W. Epperly, William B. Klimstra, Bart L. Haagmans et al. · 2020 · EBioMedicine
  5. SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801
    Angela R. Wahl, Lisa E. Gralinski, Claire E. Johnson, Wenbo Yao, Martina Kovářová, Kenneth H. Dinnon, Hongwei Liu, Victoria J. Madden, Halina M. Krzystek, Chandrav De et al. · 2021 · Nature
  6. Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications
    Drucker, Daniel J · 2020 · Endocrine Reviews
  7. T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
    William J. Liu, Min Jie Zhao, Kefang Liu, Kun Xu, Gary Wong, Wenjie Tan, George F. Gao · 2016 · Antiviral Research
  8. Transmission of MERS-Coronavirus in Household Contacts
    Christian Drosten, Benjamin Meyer, Marcel A. Müller, Victor M. Corman, Malak M. Almasri, Raheela Hossain, Hosam H. Madani, Andrea Sieberg, Berend‐Jan Bosch, Erik Lattwein et al. · 2014 · New England Journal of Medicine
  9. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment
    Susanna K. P. Lau, Candy C. Y. Lau, Kwok‐Hung Chan, Clara P. Y. Li, Honglin Chen, Dong‐Yan Jin, Jasper Fuk‐Woo Chan, Patrick C. Y. Woo, Kwok‐Yung Yuen · 2013 · Journal of General Virology
  10. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
    Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, Yu Erica Lee, Pauline R. Hoffman, Susan Ker-hwa Ou, Leesa M. Kakutani, Jennifer R. Keeffe, Hung‐Jen Wu, Mark R. Howarth, Anthony P. West et al. · 2021 · Science
  11. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
    Lu Lu, Qi Liu, Yun Zhu, Kwok‐Hung Chan, Lili Qin, Yuan Li, Qian Wang, Jasper Fuk‐Woo Chan, Lanying Du, Fei Yu et al. · 2014 · Nature Communications
  12. Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases
    Md. Abdul Alim Al‐Bari · 2017 · Pharmacology Research & Perspectives
  13. Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014
    Dianna Ng, Farida Ismail Al Hosani, M. Kelly Keating, Susan I. Gerber, Tara L. Jones, Maureen G. Metcalfe, Suxiang Tong, Ying Tao, Negar Niki Alami, Lia M. Haynes et al. · 2016 · American Journal Of Pathology
  14. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China
    Fei Yu, Lanying Du, David M. Ojcius, Chungen Pan, Shibo Jiang · 2020 · Microbes and Infection
  15. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
    Jasper Fuk‐Woo Chan, Kwok‐Hung Chan, Richard Yi Tsun Kao, Kelvin Kai‐Wang To, Bo-Jian Zheng, Clara P. Y. Li, Patrick T.W. Li, Jun Dai, Florence K.Y. Mok, Honglin Chen et al. · 2013 · Journal of Infection
  16. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)
    Yaseen M. Arabi, Abdullah F. Alharthi, J. Hussein, Abderrezak Bouchama, Sameera Al Johani, Ali H. Hajeer, B. T. Saeed, Abdullah M Al Wahbi, A. Saedy, Tarek Aldabbagh et al. · 2015 · Infection
  17. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection
    Christian Drosten, Michael Seilmaier, Victor M. Corman, W. J. Hartmann, Gregor Scheible, Stefan Sack, Wolfgang Guggemos, René Kallies, Doreen Muth, Sandra Junglen et al. · 2013 · The Lancet Infectious Diseases
  18. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk
    Romulus Breban, Julien Riou, Arnaud L Fontanet · 2013 · The Lancet
  19. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
    Yasunori Watanabe, Zachary T. Berndsen, Jayna Raghwani, Gemma E. Seabright, Joel D. Allen, Oliver G. Pybus, Jason S. McLellan, Ian A. Wilson, Thomas A. Bowden, Andrew B. Ward et al. · 2020 · Nature Communications
  20. Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
    Yanjia Chen, Xiaoyu Zhao, Hao Zhou, Huanzhang Zhu, Shibo Jiang, Pengfei Wang · 2022 · Nature reviews. Immunology
  21. Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection
    Victor M. Corman, Ali M. Albarrak, Ali Senosi Omrani, Mohammed M. Albarrak, Mohamed Elamin Farah, Malak M. Almasri, Doreen Muth, Andrea Sieberg, Benjamin Meyer, Abdullah Mufareh Assiri et al. · 2015 · Clinical Infectious Diseases
  22. COVID-19 infection in kidney transplant recipients
    Debasish Banerjee, Joyce Popoola, Sapna Shah, Irina Chis Ster, Virginia A. Quan, Mysore Keshavmurthy Phanish · 2020 · Kidney International
  23. ACE2, Much More Than Just a Receptor for SARS-COV-2
    Lobelia Samavati, Bruce D. Uhal · 2020 · Frontiers in Cellular and Infection Microbiology
  24. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity
    Chan-Ki Min, Shinhye Cheon, Na‐Young Ha, Kyung Mok Sohn, Yuri Kim, Abdimadiyeva Aigerim, Hyun Mu Shin, Ji‐Yeob Choi, Kyung‐Soo Inn, Jin Hwan Kim et al. · 2016 · Scientific Reports
  25. Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies
    Ademola Samuel Ojo, Simon Adewale Balogun, Oyeronke Titilope Williams, Olusegun Sylvester Ojo · 2020 · Pulmonary Medicine
  26. Human Infection with MERS Coronavirus after Exposure to Infected Camels, Saudi Arabia, 2013
    Ziad Ahmed Memish, Matthew L. Cotten, Benjamin Meyer, Simon J. Watson, Abdullah Jaber Alsahafi, Abdullah Abdulaziz Al Rabeeah, Victor M. Corman, Andrea Sieberg, Hatem Q. Makhdoom, Abdullah Mufareh Assiri et al. · 2014 · Emerging infectious diseases
  27. Effective inhibition of MERS-CoV infection by resveratrol
    Shih‐Chao Lin, Chi‐Tang Ho, Wen‐Ho Chuo, Shiming Li, Tony T. Wang, Chi‐Chen Lin · 2017 · BMC Infectious Diseases
  28. Diabetes, infection risk and COVID-19
    Süheda Erener · 2020 · Molecular Metabolism
  29. Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus
    Simon J. Anthony, Kirsten V. K. Gilardi, Vineet D. Menachery, Tracey Goldstein, Benard Ssebide, R. Mbabazi, Isamara Navarrete‐Macias, Eliza Liang, Heather Wells, Allison L. Hicks et al. · 2017 · mBio
  30. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
    Carly G.K. Ziegler, Vincent N. Miao, Anna H. Owings, Andrew W. Navia, Ying Tang, Joshua D. Bromley, Peter Lotfy, Meredith Sloan, Hannah Laird, Haley B. Williams et al. · 2021 · Cell
  31. Going global – Travel and the 2019 novel coronavirus
    Alfonso Javier Rodriguez-Morales, Kirsten MacGregor, Sanch Kanagarajah, Dipti Patel, Patricia Schlagenhauf · 2020 · Travel Medicine and Infectious Disease
  32. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
    Rolf Hilgenfeld, Malik J. S. Peiris · 2013 · Antiviral Research
  33. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions
    So Young Kim, Weihua Jin, Amika Sood, David W. Montgomery, Oliver C. Grant, Mark M. Fuster, Li Fu, Jonathan S. Dordick, Robert J. Woods, Fuming Zhang et al. · 2020 · Antiviral Research
  34. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment
    Adriaan H. de Wilde, Victor Stalin Raj, Diede Oudshoorn, Theo M. Bestebroer, Stefan van Nieuwkoop, Ronald W.A.L. Limpens, Clara C. Posthuma, Yvonne van der Meer, Montserrat Bárcena, Bart L. Haagmans et al. · 2013 · Journal of General Virology
  35. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
    Qianqian Zhang, Rong Xiang, Shanshan Huo, Yunjiao Zhou, Shibo Jiang, Qiao Wang, Fei Yu · 2021 · Signal Transduction and Targeted Therapy
  36. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV
    Ping‐Ing Lee, Po‐Ren Hsueh · 2020 · Journal of Microbiology Immunology and Infection
  37. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
    Dounia Darif, Ikram Hammi, Ayyoub Kihel, Imane El Idrissi Saik, Fadila Guessous, Khadija Akarid · 2021 · Microbial Pathogenesis
  38. Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein
    Wentao Li, Ruben J. G. Hulswit, Ivy Widjaja, Victor Stalin Raj, Ryan McBride, Wenjie Peng, W. Widagdo, M. Alejandra Tortorici, Brenda van Dieren, Yifei Lang et al. · 2017 · Proceedings of the National Academy of Sciences
  39. COVID-19 and diabetes: Can DPP4 inhibition play a role?
    Gianluca Iacobellis · 2020 · Diabetes Research and Clinical Practice
  40. Modified Vaccinia Virus Ankara
    Asisa Volz, Gerd Sutter · 2016 · Advances in virus research
  41. Lessons for COVID-19 immunity from other coronavirus infections
    Sariol, Alan, Perlman, Stanley · 2020 · Immunity
  42. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study
    Marcel A. Müller, Benjamin Meyer, Victor M. Corman, Malak M. Almasri, Abdulhafeez Turkestani, Daniel Ritz, Andrea Sieberg, Souhaib Aldabbagh, Berend‐Jan Bosch, Erik Lattwein et al. · 2015 · The Lancet Infectious Diseases
  43. Molecular pathology of emerging coronavirus infections
    Lisa E. Gralinski, Ralph Steven Baric · 2014 · The Journal of Pathology
  44. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study
    Matthew L. Cotten, Simon J. Watson, Paul Kellam, Abdullah A Al-Rabeeah, Hatem Q. Makhdoom, Abdullah Mufareh Assiri, Jaffar A. Al‐Tawfiq, Rafat F. Alhakeem, Hossam Madani, Fahad A. Alrabiah et al. · 2013 · The Lancet
  45. Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options
    Suliman Khan, Rabeea Siddique, Muhammad Adnan Shereen, Ashaq Ali, Jianbo Liu, Qian Bai, Nadia Bashir, Mengzhou Xue · 2020 · Journal of Clinical Microbiology
  46. Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China
    Robert L. Kruse · 2020 · F1000Research
  47. The Novel Coronavirus: A Bird's Eye View
    Parham Habibzadeh, Emily K. Stoneman · 2020 · The International Journal of Occupational and Environmental Medicine
  48. State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans
    2013 · PLoS Currents
  49. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses
    Nikhil Kirtipal, Shiv Bharadwaj, Sang Gu Kang · 2020 · Infection Genetics and Evolution
  50. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques
    Emmie de Wit, Angela L. Rasmussen, Darryl Falzarano, Trenton Bushmaker, Friederike Feldmann, Douglas L. Brining, Elizabeth R. Fischer, Cynthia Martellaro, Atsushi Okumura, Jean Chang et al. · 2013 · Proceedings of the National Academy of Sciences
  51. Broad receptor engagement of an emerging global coronavirus may potentiate its diverse cross-species transmissibility
    Wentao Li, Ruben J. G. Hulswit, Scott P. Kenney, Ivy Widjaja, Kwonil Jung, Moyasar A. Alhamo, Brenda van Dieren, Frank J. M. van Kuppeveld, Linda J. Saif, Berend‐Jan Bosch · 2018 · Proceedings of the National Academy of Sciences
  52. Evolutionary insights into host–pathogen interactions from mammalian sequence data
    Sironi, Manuela, Cagliani, Rachele, Forni, Diego, Clerici, Mario · 2015 · Nature Reviews Genetics
  53. MERS-CoV spike protein: a key target for antivirals
    Du, Lanying, Yang, Yang, Zhou, Yusen, Lu, Lu, Li, Fang, Jiang, Shibo · 2017 · Expert Opinion on Therapeutic Targets
  54. The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target
    Mohamed Abu‐Farha, Thangavel Alphonse Thanaraj, Mohammad G. Qaddoumi, Anwar M. Hashem, Jehad Ahmed Abubaker, Fahd Al‐Mulla · 2020 · International Journal of Molecular Sciences
  55. Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism
    Jung-Eun Park, Kun Li, Arlene Barlan, Anthony R. Fehr, Stanley M. Perlman, Paul B. McCray, Tom Gallagher · 2016 · Proceedings of the National Academy of Sciences
  56. Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus
    Laurence Josset, Vineet D. Menachery, Lisa E. Gralinski, Sudhakar Agnihothram, Pavel Sova, Victoria S. Carter, Boyd L. Yount, Rachel L. Graham, Ralph Steven Baric, Michael G. Katze · 2013 · mBio
  57. Middle East respiratory syndrome coronavirus (MERS-CoV): A review
    Nour Muinis Ramadan, Houssam A. Shaib · 2019 · GERMS
  58. Bats as reservoirs of severe emerging infectious diseases
    Hui-Ju Han, Huanshun Wen, Chuan‐Min Zhou, Fangfang Chen, Li-Mei Luo, Jian-Wei Liu, Xue‐jie Yu · 2015 · Virus Research
  59. Bat Origins of MERS-CoV Supported by Bat Coronavirus HKU4 Usage of Human Receptor CD26
    Qihui Wang, Jianxun Qi, Yuan Yuan, Yifang Xuan, Pengcheng Han, Yuhua Wan, Wei Ji, Yan Li, Ying Wu, Jianwei Wang et al. · 2014 · Cell Host & Microbe
  60. Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus
    Anthony R. Fehr, Rudragouda Channappanavar, Stanley M. Perlman · 2016 · Annual Review of Medicine
  61. Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response
    Eveline Kindler, Volker Thiel, Friedemann Weber · 2016 · Advances in virus research
  62. COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2
    Anshumali Mittal, Kavyashree Manjunath, Rajesh Kumar Ranjan, Sandeep Kaushik, Sujeet Kumar, Vikash Verma · 2020 · PLoS Pathogens
  63. Antibodies to combat viral infections: development strategies and progress
    Giuseppe Pantaleo, Bruno E. Correia, Craig W. Fenwick, Victor Joo, Laurent H. Perez · 2022 · Nature Reviews Drug Discovery
  64. Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus
    Scobey, Trevor, Yount, Boyd L., Sims, Amy C., Donaldson, Eric F., Agnihothram, Sudhakar S., Menachery, Vineet D., Graham, Rachel L., Swanstrom, Jesica, Bove, Peter F., Kim, Jeeho D. et al. · 2013 · Proceedings of the National Academy of Sciences
  65. Histopathology of Middle East respiratory syndrome coronovirus ( MERS ‐CoV) infection – clinicopathological and ultrastructural study
    Khaled O. Alsaad, Ali H. Hajeer, Mohammed A. Al Balwi, Mohammed Almoaiqel, Nourah Aloudah, Abdulaziz Al Ajlan, Sameera Mohammed AlJohani, Sami J. Alsolamy, Giamal Edin Mohamed Gmati, Hanan H. Balkhy et al. · 2017 · Histopathology
  66. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus
    Yang Yang, Lanying Du, Chang Liu, Lili Wang, Cuiqing Ma, Jian Tang, Ralph Steven Baric, Shibo Jiang, Fang Li · 2014 · Proceedings of the National Academy of Sciences
  67. Genetic Characterization of Betacoronavirus Lineage C Viruses in Bats Reveals Marked Sequence Divergence in the Spike Protein of Pipistrellus Bat Coronavirus HKU5 in Japanese Pipistrelle: Implications for the Origin of the Novel Middle East Respiratory Syndrome Coronavirus
    Susanna K. P. Lau, Kenneth S. M. Li, Alan K. L. Tsang, Carol S. F. Lam, Shakeel Ahmed, Honglin Chen, Kwok‐Hung Chan, Patrick C. Y. Woo, Kwok‐Yung Yuen · 2013 · Journal of Virology
  68. Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine Candidate
    Fernando Almazán, Marta L. DeDiego, Isabel Sola, Sonia Zúñiga, José L. Nieto-Torres, Silvia Márquez-Jurado, Germán Andrés, Luis Enjuanes · 2013 · mBio
  69. The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2
    Natacha S. Ogando, Jessika C. Zevenhoven-Dobbe, Yvonne van der Meer, Peter J. Bredenbeek, Clara C. Posthuma, Eric J. Snijder · 2020 · Journal of Virology
  70. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
    Razie Amraei, Nader Rahimi · 2020 · Cells
  71. Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
    Darryl Falzarano, Emmie de Wit, Cynthia Martellaro, Julie A. Callison, Vincent Jacobus Munster, Heinz Feldmann · 2013 · Scientific Reports
  72. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists
    Yang Yang, Ling Zhang, Heyuan Geng, Yao Liang Deng, Baoying Huang, Guo Yin, Zhengdong Zhao, Wenjie Tan · 2013 · Protein & Cell
  73. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain
    Zhengqian Li, Taotao Liu, Ning Yang, Dengyang Han, Xinning Mi, Yue Li, Kaixi Liu, Alain Vuylsteke, Hong‐Bing Xiang, Xiangyang Guo · 2020 · Frontiers of Medicine
  74. Antibodies against MERS Coronavirus in Dromedary Camels, United Arab Emirates, 2003 and 2013
    Benjamin Meyer, Marcel A. Müller, Victor M. Corman, Chantal B. E. M. Reusken, Daniel Ritz, Gert-Jan Godeke, Erik Lattwein, Stephan Kallies, Artem Siemens, Janko van Beek et al. · 2014 · Emerging infectious diseases
  75. The SARS‐CoV‐2 main protease (M pro ): Structure, function, and emerging therapies for COVID‐19
    Qing Hu, Yuan Xiong, Guanghao Zhu, Yani Zhang, Yi‐Wen Zhang, Ping Cheong Huang, Guang‐Bo Ge · 2022 · MedComm
  76. Receptor recognition and cross-species infections of SARS coronavirus
    Fang Li · 2013 · Antiviral Research
  77. Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors
    Park, Young-Jun, Walls, Alexandra C., Wang, Zhaoqian, Sauer, Maximillian M., Li, Wentao, Tortorici, M. Alejandra, Bosch, Berend-Jan, DiMaio, Frank, Veesler, David · 2019 · Nature Structural & Molecular Biology
  78. Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models
    Natoli, S., Oliveira, V., Calabresi, P., Maia, L. F., Pisani, A. · 2020 · European Journal of Neurology
  79. Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses
    Jingxian Zhao, Abeer N. Alshukairi, Salim Alawi Baharoon, Waleed Ahmed, Ahmad A. Bokhari, Atef Nehdi, Laila Ali Layqah, Mohammed Alghamdi, Manal Algethamy, Ashraf M. Dada et al. · 2017 · Science Immunology
  80. An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
    Bart L. Haagmans, Judith M. A. van den Brand, Victor Stalin Raj, Asisa Volz, Peter Wohlsein, Saskia L. Smits, Debby Schipper, Theo M. Bestebroer, Nisreen M.A. Okba, Robert Fux et al. · 2015 · Science
  81. Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
    Sebastiano Bruno Solerte, Francesca D’Addio, Roberto Trevisan, Elisabetta Lovati, Antonio Rossi, Ida Pastore, Marco Dell’Acqua, Elio Ippolito, Cristiana Scaranna, Rosalia Bellante et al. · 2020 · Diabetes Care
  82. Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases
    Rita M. Meganck, Ralph Steven Baric · 2021 · Nature Medicine
  83. A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates
    Kar Muthumani, Darryl Falzarano, Emma L. Reuschel, Colleen Tingey, Seleeke Flingai, Daniel O. Villarreal, Megan C. Wise, Ami R. Patel, Abdullah M. Izmirly, Abdulelah Aljuaid et al. · 2015 · Science Translational Medicine
  84. Coronaviruses: a paradigm of new emerging zoonotic diseases
    Cristiano Salata, Arianna Calistri, Cristina Parolin, Giorgio Palù · 2019 · Pathogens and Disease
  85. Coronaviruses pathogenesis, comorbidities and multi-organ damage – A review
    Kaviyarasi Renu, Pureti Lakshmi Prasanna, Abilash Valsala Gopalakrishnan · 2020 · Life Sciences
  86. ACE2 – From the renin–angiotensin system to gut microbiota and malnutrition
    Thomas Perlot, Josef Martin Penninger · 2013 · Microbes and Infection
  87. The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies
    Huihui Mou, Victor Stalin Raj, Frank J. M. van Kuppeveld, Peter J. M. Rottier, Bart L. Haagmans, Berend‐Jan Bosch · 2013 · Journal of Virology
  88. Cellular entry of the porcine epidemic diarrhea virus
    Wentao Li, Frank J. M. van Kuppeveld, Qigai He, Peter J. M. Rottier, Berend‐Jan Bosch · 2016 · Virus Research
  89. Role of the Spike Glycoprotein of Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Virus Entry and Syncytia Formation
    Zhaohui Qian, Samuel R. Dominguez, Kathryn V. Holmes · 2013 · PLoS ONE
  90. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
    Tang, Xian-Chun, Agnihothram, Sudhakar S., Jiao, Yongjun, Stanhope, Jeremy, Graham, Rachel L., Peterson, Eric C., Avnir, Yuval, Tallarico, Aimee St. Clair, Sheehan, Jared, Zhu, Quan et al. · 2014 · Proceedings of the National Academy of Sciences
  91. Natural products and their derivatives against coronavirus: A review of the non‐clinical and pre‐clinical data
    Muhammad Torequl Islam, Chandan Kumar Sarkar, Dina M. El‐Kersh, Sarmin Jamaddar, Shaikh Jamal Uddin, Jamil A. Shilpi, Mohammad Suleiman Mubarak · 2020 · Phytotherapy Research
  92. The role of extracellular vesicles in COVID-19 virus infection
    Mehdi Hassanpour, Jafar Rezaie, Mohammad Nouri, Yunes Panahi · 2020 · Infection Genetics and Evolution
  93. Membrane Binding Proteins of Coronaviruses
    Entedar A. J. Alsaadi, Ian Martin Jones · 2019 · Future Virology
  94. Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions
    Shiying Shao, Qinqin Xu, Xuefeng Yu, Ruping Pan, Yong Chen · 2020 · Pharmacology & Therapeutics
  95. Host Species Restriction of Middle East Respiratory Syndrome Coronavirus through Its Receptor, Dipeptidyl Peptidase 4
    Neeltje van Doremalen, Kerri L. Miazgowicz, Shauna Milne-Price, Trenton Bushmaker, Shelly J. Robertson, Dana P. Scott, Jöerg Kinne, Jason S. McLellan, Jiang Zhu, Vincent Jacobus Munster · 2014 · Journal of Virology
  96. Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
    Shen Wang, Bo Liang, Weiqi Wang, Lin Li, Na Feng, Yongkun Zhao, Tiecheng Wang, Feihu Yan, Songtao Yang, Xianzhu Xia · 2023 · Signal Transduction and Targeted Therapy
  97. MERS: emergence of a novel human coronavirus
    Victor Stalin Raj, Albert D. M. E. Osterhaus, Ron A. M. Fouchier, Bart L. Haagmans · 2014 · Current Opinion in Virology
  98. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
    Aleksandra Synowiec, Artur Szczepański, Emilia Barreto-Durán, Laurensius Kevin Lie, Krzysztof Pyrć · 2021 · Clinical Microbiology Reviews
  99. Is SARS-CoV-2 Also an Enteric Pathogen With Potential Fecal–Oral Transmission? A COVID-19 Virological and Clinical Review
    Siyuan Ding, T. Jake Liang · 2020 · Gastroenterology
  100. Natural products may interfere with SARS-CoV-2 attachment to the host cell
    Abdo A. Elfiky · 2020 · Journal of Biomolecular Structure and Dynamics